AngioDynamics is a leading provider of innovative medical devices used by interventional radiologists, interventional cardiologists, surgeons, and other physicians for the minimally-invasive diagnosis and treatment of cancer and peripheral vascular disease. Founded in Queensbury in 1988, AngioDynamics and has grown into a NASDAQ-listed public company. Having distinguished itself as a dynamic brand in a technologically competitive, high-growth industry, AngioDynamics sells its products in the U.S. through a direct sales force, and in international markets through a combination of direct sales and distributors. Source
No articles found.
Amicus Therapeutics (Nasdaq: FOLD) is a global, patient-centric biotechnology comp...
Amicus Therapeutics (Nasdaq: FOLD) is a global,...
GENFIT is a late-stage biopharmaceutical company dedicated to the discovery and de...
GENFIT is a late-stage biopharmaceutical compan...
We are Anchiano Therapeutics, a pivotal-stage biopharmaceutical company focused on...
We are Anchiano Therapeutics, a pivotal-stage b...
As a leading provider of innovative technologies for the treatment of Atrial Fibri...
As a leading provider of innovative technologie...
Join the National Investor Network and get the latest information with your interests in mind.